在多发性骨髓瘤中,Unc-51 Like Kinase 3 (ULK3) 对自和细胞存活至关重要
Marilena Tauro1, Tao Li1, Praneeth R Sudalagunta2
1Department of Tumor Microenvironment & Metastasis, H. Lee Moffitt Cancer Center and Research Institute; Tampa, FL, USA.
Research square
|August 20, 2025
概括
针对ULK3,一个关键的自基因,为多发性骨髓瘤 (MM) 提供了一种新的策略. 抑制ULK3可降低瘤负担,并恢复耐药性MM患者的药物敏感性.
科学领域:
- 癌症学
- 分子生物学
- 细胞生物学
背景情况:
- 多发性骨髓瘤 (MM) 经常在耐火性疾病中复发,尽管目前使用的是蛋白酶体抑制剂.
- 确定新的治疗点对于改善MM患者的治疗结果至关重要.
研究的目的:
- 研究自基因在多发性骨髓瘤进展中的作用.
- 评估ULK3作为MM治疗的潜在治疗标.
主要方法:
- 对813个CD138+MM患者样本进行RNA测序分析.
- 在MM细胞生存中ULK3的功能研究.
- 产生和测试ULK3抑制剂 (SG3-014/MA9-060).
- 在小鼠模型中的体内研究和患者样本的体外验证.
主要成果:
- 鉴定了自基因特征,特别是ULK3表达与MM疾病进展之间的强烈关联.
- 抑制ULK3降低了MM瘤负担,改善了生存率,并在体内保护了骨疾病.
- ULK3抑制剂MA9-060恢复了耐药MM细胞对蛋白酶抑制剂的敏感性,在患者样本中验证了协同作用.
结论:
- ULK3 在MM细胞存活和通过自的疾病进展中起着重要作用.
- 对于新诊断的多发性骨髓瘤和耐火性多发性骨髓瘤,ULK3抑制是一种有前途的治疗策略.
- 联合ULK3抑制和蛋白酶抑制剂治疗显示出克服MM药物耐药性的潜力.
相关概念视频
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.9K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.9K
Autophagy
4.6K
Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
4.6K
Autophagic Cell Death
3.5K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
3.5K
The Intrinsic Apoptotic Pathway
6.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.8K


